Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 67 for “"A - synuclein"”.
-
DISSECTING THE INTERACTION OF a-SYNUCLEIN WITH TUBULIN/MICROTUBULES
… neurons and the accumulation and misfolding of α-synuclein. Remarkably, PD is even the fastest-growing neurological disorder; by 2040, the number of PD patients worldwide is expected to exceed 12 million. Despite tremendous scientific research and financial investments in PD, a cure for this …
-
Effect of degradation systems in a-‐synuclein intracellular levels and release
H νόσος του Πάρκινσον (ΝΠ), είναι η δεύτερη πιο κοινή νευροεκφυλιστική διαταραχή μετά τη νόσο του Αλτσχάιμερ (ΝΑ) και χαρακτηρίζεται από την προοδευτική απώλεια των ντοπαμινεργικών νευρώνων στην μέλαινα ουσία pars compacta. Χαρακτηριστικό γνώρισμα της νόσου είναι η παρουσία ενδονευρωνικών …
-
Investigating the ATP13A2 (PARK9) and a- Synuclein inter-relationship in Parkinson’s Disease
… by the intra-neuronal aggregation of the a-Synuclein protein, which impairs cellular functions promoting neurodegeneration. The deposition of aggregated a-Synuclein progresses through the brain in a stereotypical manner. The dopaminergic neurons of the SNpc are most susceptible to …
-
Automated protein NMR data analysis and its application to a-synuclein fibrils
… methods to the problems of refining an a-synuclein fibril structure with proton-detected NMR data, the analysis and characterization of a pair of interrelated a-synuclein fibril strains with distinct pathological properties, and to the general question of fibril polymorphism, a phenomenon …
-
Establishment of Primary Culture Models of Multiple System Atrophy Based on Expression of a-Synuclein in Oligodendrocytes
… cytoplasmic inclusions (GCIs) composed of a-synuclein. I have developed cell culture models of MSA based on overexpression of human a-synuclein in primary mouse oligodendrocytes. In oligodendrocytes derived from (PLP)-a-synuclein transgenic mice, elevation of a-synuclein levels by proteasome …
-
Elucidating the Endogenous Distribution, Topography, and Cells-of-Origin of a-synuclein in Relation to Parkinson’s Disease
… brain. Lewy bodies are composed of aggregated a-synuclein protein, and although essential to our understanding of PD, not much is known about the native, pre-synaptic state of a-synuclein (a-syn). Due to its mostly synaptic local, immunostaining results in diffuse signal, ultimately providing …
-
Investigation of the presence of a-synuclein deposits in the skin of patients with familial Parkinson Disease mutations
Η Nόσος Πάρκινσον (ΝΠ) είναι μια νευροεκφυλιστική ασθένεια που επηρεάζει ένα σημαντικό ποσοστό του πληθυσμού παγκοσμίως. Το παθογνωμονικό χαρακτηριστικό της PD είναι η λανθασμένη αναδίπλωση της πρωτεΐνης που ονομάζεται α-συνουκλεΐνη. Η λανθασμένη αναδίπλωση της Α-συνουκλεΐνης χαρακτηρίζει επίσης …
-
Investigating the impact of alterations in alpha-synuclein on mitochondrial health, mitochondrial quality control and neuronal differentiation
… but have been linked to the aggregation of a-synuclein; a protein which pathologically forms intracellular inclusions, known as Lewy bodies, in PD brains. A relationship between a-synuclein and mito-QC has been established based on the presence of dysfunctional mitochondria in both PD patients …
-
Regulation of Weibel-Palade Body Exocytosis by alpha-Synuclein in Endothelial Cells
a-Synuclein (a-syn) is a small presynaptic protein implicated in the pathogenesis of Parkinson’s disease. Although gathering evidence has been proposed for its physiological roles, the precise roles of a-synuclein and mechanisms remain incompletely understood. a-Synuclein is not only expressed in …
-
Evaluation of neuropathology and neurodegeneration in experimental models of Parkinson’s disease based on alpha synuclein preformed fibrils or 6-hydroxydopamine
… (LNs) that are composed primarily of misfolded a-synuclein. a-Synuclein pathology spreads to different regions of the brain as disease progresses and the presence of LBs and LNs correlate closely with the clinical features of PD. However, it is not yet understood which events are necessary to …
-
Ρύθμιση των επιπέδων της α-συνουκλεΐνης, πρωτεΐνης η οποία ενέχεται στη νόσο του Parkinson
… unclear, accumulation and polymerization of a-synuclein, a low molecular weight neuronal protein, is believed to hold a central role in the process. Our study focuses on a-synuclein homeostasis addressing the whole issue in three different levels: 1. Induction of Chaperone Mediated Autophagy in …
-
Διερεύνηση του μηχανισμού δράσης της εκκρινόμενης ασυνουκλεΐνης: επιπτώσεις στην παθογένεια και στην εξέλιξη της νόσου Πάρκινσον
… we studied the secretion mechanisms of alpha-synuclein and its effect on cell homeostasis. The study was performed by using proliferating SH-SY5Y neuroblastoma cell lines inducible expressing wild type (WT) α-synuclein. Τhe effect of chemical compounds, that inhibit specific non-classical …
-
Drug Candidates Targeting Hsp90/Cdc37 for the Treatment of Neurodegenerative Disease
… which are linked to abnormalities in Tau and a-synuclein proteins, respectively. Currently, there is no cure for these diseases. Our group and others have shown that chaperone proteins play a critical role in the processing of Tau and a-synuclein. The inhibition of the Hsp90/Cdc37 chaperone …
-
MODELLING PARKINSON'S DISEASE USING HUMAN MIDBRAIN-LIKE ORGANOIDS
… midbrain dopaminergic neurodegeneration and a-synuclein aggregation in 'Lewy bodies' are well-established disease hallmarks, but underlying molecular mechanisms remain unclear and no disease-modifying treatments have been successfully developed, perhaps due in part to a historical shortage of …
-
Μελέτη της επίδρασης των πρωτεϊνών με αμυλοειδή χαρακτηριστικά στην παθογένεια και εξέλιξη των νευροεκφυλιστικών νόσων
α-Synuclein, α small neuronal protein enriched in synaptic terminals, is biochemically and genetically linked to Parkinson's disease. α-Synuclein is the main protein component of Lewy bodies and neurites, which are the major pathological hallmarks of Parkinson's disease and other synucleinopathies. …
-
Monitoring Pathological Gene Expression and Studying Endogenous Epigenetic Architecture by CRISPR/Cas9-based Tool Development using alpha-Synuclein as a Model
… of a causative gene in Parkinson's disease, a-synuclein. We use CRISPR/Cas9 to insert a highly sensitive engineered luciferase at the C-terminal of a-synuclein and assessed its responses to stimuli. Our system responds to epigenetic stimuli, which was unable to be recapitulated by previously …
-
Cerebrovascular contributions to Lewy body diseases and associated disorders
… abnormal accumulation of a protein known as a-synuclein. This protein aggregates to form Lewy bodies and Lewy neurites in specific brain regions. A major research focus is on understanding why a-synuclein accumulates in vulnerable regions of the brain, and how this drives neurodegeneration and …
-
Potential interaction between LRRK2 and alpha synuclein drives dopaminergic neuron loss
… of hyper-phosphorylated and ubiquinated α-synuclein (SNCA), known as Lewy Bodies. Conserved LB pathology in α-synuclein and LRRK2 mediated disease suggests a common pathological pathway in disease progression. In order to address the potential disease-relevant nexus between these two …
-
The Unfolded Protein Response : A potential link between heterozygous mutations in GBA1 and Lewy body dementia?
… (LBD) is characterised by the deposition of a-synuclein containing Lewy bodies throughout cortical brain regions. Pathology is confounded by the co-occurrence of pathological Ab and tau deposition. LBD comprises dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), …
Page 1 of 4